At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 412 target
Drug / intervention
Immediate angioplastyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immediate Angioplasty For Acute Ischemic Stroke With Severe Intracranial Atherosclerotic Stenosis (MAGIC): A Multicenter, Prospective, Open-label, Blinded Endpoint, Randomized Controlled Trial
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University·interventional·Posted May 31, 2024·Updated May 25, 2025
In Brief
A clinical study evaluating Immediate angioplasty for Stroke, Acute Ischemic. Currently recruiting, targeting 412 participants across 2 sites.
Signals
Enrolling ahead of pace
Detailed Summary
A multicenter, prospective, open-label, blinded endpoint, randomized controlled trial that aims to evaluate the effect of immediate angioplasty (with or without stenting) for acute ischemic stroke (AIS) with severe intracranial atherosclerotic stenosis (ICAS) in improving the 90-day functional outcome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Acute Ischemic
CountriesChina
CollaboratorsShenzhen Hospital of Southern Medical University
Timeline
N/ARecruiting
202520262027202820292030
First PostedMay 2024
Enrollment StartMay 2025
TodayJul 2026
Primary CompletionDec 2029
First PostedMay 31, 2024
Enrollment StartMay 8, 2025
Primary CompletionDec 1, 2029
TodayJul 1, 2026
Enrollment to primary: 4.6 yearsPosted 2.1 years agoPrimary completion in 3.4 years
Interventions
Immediate angioplastyprocedure
See arm/group descriptions.